Headquarters
San Francisco, CAFounded
2021CEO / Founder
Dereck PaulEmployees
11-50Funding
SeedProducts
1 product listedAvg. AI Score
7.6/10Website
glass.health/Profile updated
Glass Health is a San Francisco-based healthcare technology company founded in 2021 by Dereck Paul and Ethan Steinberg, both of whom have backgrounds in medicine and software engineering. The company builds AI-powered tools designed to reduce administrative burden on clinicians and support clinical reasoning at the point of care.
The platform's primary products include an ambient scribe that automatically generates clinical notes from patient-physician conversations, and a clinical decision support tool that assists with differential diagnosis and treatment planning. Glass Health targets individual clinicians, group practices, and health systems, positioning its tools as workflow aids rather than autonomous diagnostic systems.
Glass Health raised early-stage funding to develop its platform, though the specific total amount has not been publicly disclosed. The company operates with a small team and has grown its user base among physicians seeking to reduce documentation time. Co-founder Dereck Paul has been active in articulating the company's approach to responsible AI deployment in clinical settings.
Dated, source-cited figures. Estimates are marked.
All products by Glass Health reviewed by our AI panel of experts.
Six independent reviewer personalities assessed Glass Health's product on their own terms. They disagreed by 1.3 points — The Skeptic was the hardest to convince, The Domain Practitioner the most positive.
Averaged across 1 reviewed product in our catalog. Scores are out of 10.
Who Glass Health competes with, and how they differ.
OpenEvidence is a point-of-care clinical answer engine built on medical-literature search for fast lookups during a visit, while Glass generates structured differential diagnoses and full assessment-and-plan drafts from an entered patient summary — a heavier, documentation-oriented workflow rather than a quick-reference tool.
1 product reviewed on TopReviewedAbridge focuses primarily on ambient clinical documentation and scribing sold into large health systems with deep EHR integration, whereas Glass combines scribing with diagnosis and treatment-planning decision support aimed more at individual clinicians and smaller practices before moving upmarket.
1 product reviewed on TopReviewedNabla is an ambient AI scribe and clinical documentation assistant spanning multiple EHRs with a similar physician-facing workflow and pricing model to Glass, making it a closer functional peer than the larger, more EHR-embedded incumbents.
1 product reviewed on TopReviewedAmbience Healthcare pairs ambient documentation with billing and coding automation across 200+ specialties — the closest structural match to Glass's combined scribe-plus-CDS model, but weighted toward coding and revenue-cycle value rather than diagnostic reasoning.
1 product reviewed on TopReviewedSuki AI is a voice-first assistant focused on dictation, coding and EHR task automation for clinicians, competing with Glass mainly on documentation efficiency rather than on diagnostic decision support.
1 product reviewed on TopReviewedKey milestones in Glass Health's history, with sources.
Included as one of four clinical-AI tools in the Harvard/Stanford ARISE NOHARM safety benchmark
Glass Health was one of four clinical decision-support tools (alongside AMBOSS LiSA, Doximity Ask and OpenEvidence) evaluated in the Stanford Medicine/Harvard Medical School-affiliated ARISE NOHARM clinical-AI safety study; independent physician commentary reported that clinical RAG tools as a group had lower severe-error rates than generalist LLMs in the study. Per-tool ranking figures circulating in vendor marketing were not independently verified here and are not recorded.
healthcarehuddle.comExpanded from diagnosis support into ambient clinical documentation
Independent healthcare-AI commentary (Dr. Kola Tytler) reported Glass Health had expanded its product to combine ambient visit-dialogue capture with EHR data to draft H&P, progress and discharge notes with inline references, moving beyond its original diagnosis-support-only scope.
iatrox.comSeed — $5M led by Initialized Capital
Glass Health announced a $5 million seed round led by Initialized Capital, with participation from Afore Capital, Founder Collective, OpenView Venture Partners, Quiet Capital, XFactor Ventures, and healthcare-founder angels including Tom X Lee, Connor Landgraf, Heather Hasson and Trina Spear.
wilmerhale.comLaunched Glass AI, an LLM-based diagnosis and clinical-plan assistant
Glass Health launched "Glass AI," pivoting from its original clinician notebook product to a large-language-model tool that generates candidate diagnoses and draft clinical plans from a patient summary, combined with physician-reviewed clinical guidelines.
ycombinator.comPre-seed — $1.5M led by Breyer Capital
Glass Health raised a $1.5 million pre-seed round led by Breyer Capital in 2022, before joining Y Combinator's Winter 2023 batch.
techcrunch.comFounded by Dereck Paul and Graham Ramsey
Dereck Paul, then a UCSF medical student, and Graham Ramsey, an engineer at Modern Fertility, co-founded Glass Health in San Francisco in 2021 to build software for physicians to store, organize and share their diagnostic and treatment approaches.
techcrunch.comBrowse multi-perspective AI panel reviews across hundreds of AI tools, agents, and platforms. Find the right software with insights from CTO, Developer, Marketer, Finance, and User perspectives.